food-and-drug-administration

Documents about food-and-drug-administration

• HHSF22317001 — BOOZ ALLEN HAMILTON INC — Department of Health and Human Services ($43,729,877)#601772USAspending
• 75F40121F19001 — ACCENTURE FEDERAL SERVICES LLC — Department of Health and Human Services ($36,294,817)#601949USAspending
• HHSF22316001 — SAPIENT GOVERNMENT SERVICES, INC. — Department of Health and Human Services ($31,456,464)#602092USAspending
• 75F40124F19001 — INTERNATIONAL CONSULTING ASSOCIATES, INC. — Department of Health and Human Services ($30,265,233)#602137USAspending
• 75F40121F19002 — BOOZ ALLEN HAMILTON INC — Department of Health and Human Services ($29,784,497)#602155USAspending
• 75F40121F19001 — BOOZ ALLEN HAMILTON INC — Department of Health and Human Services ($29,127,717)#602185USAspending
• 75F40122F19003 — BOOZ ALLEN HAMILTON INC — Department of Health and Human Services ($22,808,429)#602564USAspending
• 75F40123F19018 — BOOZ ALLEN HAMILTON INC — Department of Health and Human Services ($22,246,516)#602602USAspending
• HHSF22316001 — DELL MARKETING L.P. — Department of Health and Human Services ($20,844,019)#602716USAspending
• 21 CFR Part 1240 — Control of Communicable Diseases#506937Code of Federal Regulations (eCFR)
• Assessment of the Human Systemic Absorption of Sunscreen Ingredients#912935ClinicalTrials.gov
• Risky Business? The Trump Administration and the State-Licensed Marijuana Industry#1019560Scholarship@Vanderbilt Law
• Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions; Guidance for Industry and Food and Drug Administration Staff; Availability#512192Federal Register
• Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 1, Nutrient Considerations.#125498NCBI PubMed Central
• 21 CFR Part 1210 — Regulations Under the Federal Import Milk Act#506935Code of Federal Regulations (eCFR)
• 21 CFR Part 1230 — Regulations Under the Federal Caustic Poison Act#506936Code of Federal Regulations (eCFR)
• Venous thromboembolism with combined oral contraceptives based on estrogen and progestin content: a disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database#159210HAL (France)
• 21 CFR Part 1271 — Human Cells, Tissues, and Cellular and Tissue-Based Products#506939Code of Federal Regulations (eCFR)
• 75F40122F19004 — GENERAL DYNAMICS INFORMATION TECHNOLOGY, INC. — Department of Health and Human Services ($30,055,179)#602142USAspending
• 75F40124F80048 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($22,498,224)#602585USAspending
• 75F40125F80029 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($21,507,334)#602656USAspending
• Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 2, Regulatory and Safety Considerations.#125497NCBI PubMed Central
• Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system.#976664PubMed
• Large Language Models for World Health Organization-Uppsala Monitoring Centre Drug-Adverse Event Causality Assessment Using Food and Drug Administration Adverse Event Reporting System Cases: Comparative Performance Study.#395989NCBI PubMed Central
• 75F40124F19007 — FOUR POINTS TECHNOLOGY, L.L.C. — Department of Health and Human Services ($38,613,587)#601885USAspending
• 75F40122F19006 — FOUR POINTS TECHNOLOGY, L.L.C. — Department of Health and Human Services ($29,935,451)#602150USAspending
• 75F40125F19001 — FOUR POINTS TECHNOLOGY, L.L.C. — Department of Health and Human Services ($29,599,019)#602162USAspending
• 21 CFR Part 329 — Nonprescription Human Drug Products Subject to Section 760 of the Federal Food, Drug, and Cosmetic Act#506820Code of Federal Regulations (eCFR)
• Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone#914322ClinicalTrials.gov
• Effects of repeated nalfurafine and VZTK35 treatments on fentanyl/cocaine mixture self-administration in a rat drug-vs.-food choice procedure.#923555NCBI PubMed Central
• Human-in-the-loop artificial intelligence for drug-shortage recurrence-risk ranking and synthetic inventory-policy simulation using U.S. Food and Drug Administration Data#663440Springer Nature OA
• 21 CFR Part 202 — Prescription Drug Advertising#506792Code of Federal Regulations (eCFR)
• 21 CFR Part 203 — Prescription Drug Marketing#506793Code of Federal Regulations (eCFR)
• 21 CFR Part 216 — Human Drug Compounding#506803Code of Federal Regulations (eCFR)
• 21 CFR Part 101 — Food Labeling#506731Code of Federal Regulations (eCFR)
• 21 CFR Part 170 — Food Additives#506773Code of Federal Regulations (eCFR)
• State Mifepristone Regulation Following GenBioPro v Raynes#168659Digital Commons @ American University Washington College of Law
• Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database.#193619NCBI PubMed Central
• 21 CFR Part 130 — Food Standards: General#506752Code of Federal Regulations (eCFR)
• 21 CFR Part 171 — Food Additive Petitions#506774Code of Federal Regulations (eCFR)
• 21 CFR Part 169 — Food Dressings and Flavorings#506772Code of Federal Regulations (eCFR)
• Food and Drug Administration's regulation of dietary supplements : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, July 20, 1993#334152Internet Archive
• 21 CFR Part 174 — Indirect Food Additives: General#506777Code of Federal Regulations (eCFR)
• 21 CFR Part 177 — Indirect Food Additives: Polymers#506780Code of Federal Regulations (eCFR)
• 21 CFR Part 181 — Prior-Sanctioned Food Ingredients#506784Code of Federal Regulations (eCFR)
• 21 CFR Part 208 — Medication Guides for Prescription Drug Products#506797Code of Federal Regulations (eCFR)
• 21 CFR Part 312 — Investigational New Drug Application#506813Code of Federal Regulations (eCFR)
• Minimum clinically important differences in acute pain: a patient-level re-analysis of randomized controlled analgesic trials submitted to the US Food and Drug Administration.#165763NCBI PubMed Central
• Assessing the abuse liability of U.S. Food and Drug Administration-authorized electronic nicotine delivery systems: Impact of nicotine flux, flavor, and menthol cigarette smoking status.#371581NCBI PubMed Central
• 21 CFR Part 173 — Secondary Direct Food Additives Permitted in Food for Human Consumption#506776Code of Federal Regulations (eCFR)